Savara (SVRA) Intangibles (2014)

Savara (SVRA) reported Intangibles of $2.0 million for Q3 2014, little changed quarter-over-quarter from $2.0 million in Q2 2014.

Savara (SVRA) Intangibles (2014) Analysis & Trends

Savara (SVRA) has 1 years of Intangibles data on file, last reported at $2.0 million in Q3 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Intangibles (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	4.41 Mn
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	30.30 Mn
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	418.50 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	7.73 Mn
10	Savara	1.39 Bn	1.39 Bn	-	-

Download Data